S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 97.5 TWD -0.51% Market Closed
Market Cap: 11.7B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Long-Term Investments
NT$454.8m
CAGR 3-Years
55%
CAGR 5-Years
40%
CAGR 10-Years
25%
Y
YungShin Global Holding Corp
TWSE:3705
Long-Term Investments
NT$1.2B
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
0%
Formosa Laboratories Inc
TWSE:4746
Long-Term Investments
NT$1.8B
CAGR 3-Years
-13%
CAGR 5-Years
17%
CAGR 10-Years
21%
ScinoPharm Taiwan Ltd
TWSE:1789
Long-Term Investments
NT$80.3m
CAGR 3-Years
-40%
CAGR 5-Years
-34%
CAGR 10-Years
-12%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Long-Term Investments
NT$3.1B
CAGR 3-Years
105%
CAGR 5-Years
44%
CAGR 10-Years
44%
Standard Chem & Pharm Co Ltd
TWSE:1720
Long-Term Investments
NT$1.6B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
11%
No Stocks Found

SCI Pharmtech Inc
Glance View

Market Cap
11.7B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
47.61 TWD
Overvaluation 51%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Long-Term Investments?
Long-Term Investments
454.8m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Long-Term Investments amounts to 454.8m TWD.

What is SCI Pharmtech Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
25%

Over the last year, the Long-Term Investments growth was -27%. The average annual Long-Term Investments growth rates for SCI Pharmtech Inc have been 55% over the past three years , 40% over the past five years , and 25% over the past ten years .

Back to Top